Histological evaluation of hysterectomy specimens after NovaSure® endometrial ablation in patients with atypical endometrial hyperplasia or endometrial carcinoma

Abstract Background Treatment with NovaSure® endometrial ablation is approved for patients with heavy menstrual bleeding (HMB) without evidence of malignant or premalignant lesions. This analysis addresses the rare but clinically relevant situation in which endometrial carcinoma (EC) or atypical hyp...

詳細記述

書誌詳細

出版年:	Archives of Gynecology and Obstetrics
主要な著者:	Oliver M. Schleicher, Alaa Hamzeh, Julia Gocke, Patrik Poeschke, Frederik A. Stuebs, Stefanie Burghaus, Felix Heindl, Arndt Hartmann, Matthias W. Beckmann, Christian Matek, Julius Emons
フォーマット:	論文
言語:	英語
出版事項:	Springer 2026-06-01
主題:	NovaSure® endometrial ablation atypical endometrial hyperplasia endometrial carcinoma
オンライン･アクセス:	https://doi.org/10.1007/s00404-026-08497-x